Format

Send to

Choose Destination
Drug Discov Today. 2007 Jan;12(1-2):28-33. Epub 2006 Oct 30.

Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens.

Author information

1
Department of Genetics, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA. perrimon@receptor.med.harvard.edu

Abstract

RNA interference (RNAi) and small-molecule approaches are synergistic on multiple levels, from technology and high-throughput screen development to target identification and functional studies. Here, we describe the RNAi screening platform that we have established and made available to the community through the Drosophila RNAi Screening Center at Harvard Medical School. We then illustrate how the combination of RNAi and small-molecule HTS can lead to effective identification of targets in drug discovery.

PMID:
17198970
DOI:
10.1016/j.drudis.2006.10.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center